<DOC>
	<DOCNO>NCT01057147</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy 2 % rebamipide compare placebo clear fluorescein stain central cornea subject dry eye disease .</brief_summary>
	<brief_title>Safety Efficacy Study Rebamipide 2 % Ophthalmic Suspension Subjects With Dry Eye - Effects Central Cornea</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age 18 year old Diagnosis dry eye define protocol Central corneal stain Ongoing ocular disease may interfere study parameter Inability stop use topical ophthalmic medication throughout duration study Inability stop use contact lenses duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>